Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 17% in that time frame, underperforming the S&P 500. Will the recent negative trend continue lead...